- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €337.6m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.68
7D
2.1%
1Y
-33.1%
Heidelberg Pharma
Market Cap: €120.2m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally.
HPHA
€2.55
7D
-4.5%
1Y
-44.1%
Novogenia
Market Cap: €95.4m
Operates in the healthcare industry.
7V0
€7.95
7D
0%
1Y
4.6%
Cantourage Group
Market Cap: €77.3m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.20
7D
-1.0%
1Y
19.7%